Global Anticoagulant Reversal Drugs Market Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214623
April 2021
Report Formats:

Global Anticoagulant Reversal Drugs Market Overview 
The key driver impacting the anticoagulant reversal drugs market is the growing prevalence of bleeding disorders and the rise in the incidence of indications for anticoagulant therapy. For instance, As per the National Institutes of Health, bleeding disorders allegedly affect 1 in 1,000 men and women worldwide. Haemophilia A and B and von Willebrand disease make up the most widespread types of bleeding disorders. As per the National Hemophilia Foundation (NHF) data, around 30,000 to 33,000 people have hemophilia, and 60% have serious hemophilia. The Center for disease control and prevention (CDC) reports estimations every year. Around 400 babies born with hemophilia A in the U.S. Von Willebrand disease are considered the most common bleeding disorders that affected 1 in every 100 people. Moreover, the growing approval and launch of new reversal agents for anticoagulants is estimated to be a significant factor contributing to market growth.

According to Value Market Research, the global anticoagulant reversal drugs market size was valued at around USD 700 million in 2020 and is projected to grow at a CAGR of about 14% during the forecast period of 2021 to 2027.

The rise in the global prevalence of multiple cardiovascular indications such as atrial fibrillation, rise in intracranial and gastrointestinal hemorrhages with the growing geriatric population is estimated to augment anticoagulant reversal drugs demand in the forecast period. For instance, Cardiovascular diseases (CVDs) are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. CVDs refer to the group of heart and blood vessel disorders and include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. However, the high cost of reversal therapies may hamper the global anticoagulant reversal drugs market in the long run. The current industry trends, such as the rise in governments’ financial aid encouraging the creation of effective therapeutics, are expected to provide market players with new market opportunities.

The anticoagulant reversal drugs market is vast, with many local and global players. The key leaders follow different strategies to advance their market position, such as contracts, amalgamation, extending product portfolio, expansions, acquisitions, and product upgrades to raise their market share across the globe. The major players in the report are Portola Pharmaceuticals, CSL Behring, Boehringer Ingelheim, Octapharma AG, AMAG Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Pfizer, Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Octapharma AG, SGPharma Pvt. Ltd., and Alps Pharmaceutical Ind. Co., Ltd.

Global Anticoagulant Reversal Drugs Market Share

In this research report, the anticoagulant reversal drugs market is segmented by product type, distribution channel, and region.

Analysis by Product Type:
By Product type, the report is categorized into prothrombin complex concentrates, phytonadione, andexanet alfa, idarucizumab, protamine, and others. The idarucizumab segment dominates the product type segment with over 35% share in 2020. It is due to the high revenue generation by idarucizumab in significant geographies. Moreover, the growing usage of idarucizumab in patients treated with dabigatran when there is a requirement of reversal of the anticoagulant effects is required for urgent procedures or uncontrolled incidents or life-threatening bleeding driving demand for idarucizumab in the forecast period. 

Analysis by Distribution Channel:
By distribution channel, the report is categorized into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominates the distribution channel segment with over 50% share in 2020. It is due to the hospitals being the primary centers for diagnosing and treating various types of bleeding disorders. Moreover, uncontrolled bleeding during emergency conditions  contributes to the high market demand from distribution channels in the forecast period.

Analysis by Region:
In the regional outlook of the global anticoagulant reversal drugs market, the North America region dominates with a 40% market share during the forecast period. It is due to the high healthcare expenditure and favorable healthcare reimbursement policies for costly drugs throughout the region. The increasing awareness and rising incidence of bleeding disorders in the region add growth to the region. Moreover, the easy availability of these reversal drugs during emergency conditions contributes to the development of the anticoagulant reversal drugs market in North America.

Market Segmentation covered in the Report:
By Product Type
  • Prothrombin Complex Concentrates
  • Phytonadione
  • Andexanet Alfa
  • Idarucizumab
  • Protamine
  • Others
 By Distribution Channel 
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
 By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.  

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . ANTICOAGULANT REVERSAL DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product Type
           3.7.2 By Distribution Channel
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ANALYSIS BY PRODUCT TYPE
       6.1 Overview by Product Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Product Type
       6.4 Prothrombin Complex Concentrates Market by Regions
       6.6 Phytonadione Market by Regions
       6.5 Andexanet Alfa Market by Regions
       6.7 Idarucizumab Market by Regions
       6.8 Protamine Market by Regions
       6.9 Others Market by Regions
 
7 . GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Historical and Forecast Data
       7.3 Analysis by Distribution Channel
       7.4 Hospital Pharmacy Market by Regions
       7.5 Retail Pharmacy Market by Regions
       7.6 Online Pharmacy Market by Regions
 
8 . GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT REVERSAL DRUGS COMPANIES
       9.1. Anticoagulant Reversal Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF ANTICOAGULANT REVERSAL DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Portola Pharmaceuticals
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. CSL Behring
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Boehringer Ingelheim
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Octapharma AG
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. AMAG Pharmaceuticals, Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Dr. Reddy's Laboratories
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Pfizer, Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Fresenius Kabi AG
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Bausch Health Companies Inc.
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Octapharma AG, SGPharma Pvt. Ltd.
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Alps Pharmaceutical Ind. Co. Ltd.
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product Type (USD MN)
  •  Prothrombin Complex Concentrates Market by Geography (USD MN)
  •  Phytonadione Market by Geography (USD MN)
  •  Andexanet Alfa Market by Geography (USD MN)
  •  Idarucizumab Market by Geography (USD MN)
  •  Protamine Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Analysis Market by Distribution Channel  (USD MN)
  •  Hospital Pharmacy Market by Geography (USD MN)
  •  Retail Pharmacy Market by Geography (USD MN)
  •  Online Pharmacy Market by Geography (USD MN)
  •  Global Anticoagulant Reversal Drugs Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Anticoagulant Reversal Drugs Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Anticoagulant Reversal Drugs Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product Type
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product Type (USD MN)
  •  Prothrombin Complex Concentrates Market by Geography (USD MN)
  •  Phytonadione Market by Geography (USD MN)
  •  Andexanet Alfa Market by Geography (USD MN)
  •  Idarucizumab Market by Geography (USD MN)
  •  Protamine Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel  (USD MN)
  •  Hospital Pharmacy Market by Geography (USD MN)
  •  Retail Pharmacy Market by Geography (USD MN)
  •  Online Pharmacy Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials